To test the anti-tumor efficacy of TRAIL-ATNCIL4rP, we first established orthotopic pancreatic tumor models by injecting luciferase-expressing BxPC3 cells, a TRAIL-sensitive human PDAC cell line67, into the pancreatic parenchyma of male BALB/c nude mice. This evidence concerns the gene TNFSF10 and neoplasm.